Natural products modulating interleukins and other inflammatory mediators in tumor-bearing animals: A systematic

Gopalsamy Rajiv Gandhi1, Poovathumkal James Antony2, Maria Júlia Miranda de Paula Lana3

  • 1Postgraduate Program in Health Sciences, Federal University of Sergipe, Prof. João Cardoso Nascimento Campus, Aracaju, Sergipe 49060-108, Brazil.

Abstract

Insights

Natural products show promise in cancer management by modulating interleukins (ILs) and related inflammatory pathways. Further clinical trials are needed to confirm the anticancer benefits of these natural compounds.

Area of Science:

  • Oncology
  • Immunology
  • Pharmacology

Background:

  • Cancer is characterized by uncontrolled cell growth.
  • Natural products offer bioactive compounds for cancer management.
  • These compounds modulate biological events, including interleukins (ILs) and inflammatory pathways.

Purpose of the Study:

  • To systematically review in vivo studies on medicinal plants and natural molecules.
  • To investigate their role in modulating ILs and inflammatory markers in tumor-bearing animals.

Main Methods:

  • Literature search of PubMed, Embase, Scopus, and Web of Science (Jan 2010-Jan 2022).
  • Search terms included medicinal plants, anticancer, ILs, and cytokines.
  • Manual search and critical review of identified articles.

Main Results:

  • Natural products modulate various ILs (e.g., IL-1β, IL-6, IL-12) and interferon gamma.
  • They affect key cancer-related molecules like TNF-α, VEGF, and NF-κB.
  • Immune augmentation and enhanced antioxidant activity were observed.

Conclusions:

  • Natural products demonstrate significant potential in regulating ILs and associated inflammatory markers.
  • Phytochemicals like flavonoids and polyphenols are key modulators, especially of pro-inflammatory ILs.
  • Clinical trials are warranted to validate these anticancer properties.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
693
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
9.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
216